These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10967878)

  • 21. [Evaluation of the effectiveness of targeted vaccination with the meningococcal polysaccharide A and C vaccine in one location in the Czech Republic].
    Krízová P; Vlcková J; Bobák M
    Epidemiol Mikrobiol Imunol; 1995 Mar; 44(1):9-14. PubMed ID: 7757351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Vaccination Project-88. New Norwegian vaccine against type B meningitis--what happened?].
    Rød KA
    Fag Tidsskr Sykepleien; 1990 Jan; 78(1):27-31. PubMed ID: 2109367
    [No Abstract]   [Full Text] [Related]  

  • 23. Meningitis vaccination in Auckland.
    Newman J
    N Z Med J; 1987 Oct; 100(833):636. PubMed ID: 3132658
    [No Abstract]   [Full Text] [Related]  

  • 24. Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine.
    Richmond P; Kaczmarski E; Borrow R; Findlow J; Clark S; McCann R; Hill J; Barker M; Miller E
    J Infect Dis; 2000 Feb; 181(2):761-4. PubMed ID: 10669372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of antibody response in meningococcal patients, contacts and vaccinees in north India.
    Rao B; Ayyagari A; Sharma M
    Trop Geogr Med; 1991; 43(1-2):111-3. PubMed ID: 1750098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Commentary: prophylaxis for contacts of patients with meningococcal disease.
    Gold R
    Pediatr Infect Dis; 1982; 1(2):139-40. PubMed ID: 6817315
    [No Abstract]   [Full Text] [Related]  

  • 27. Meningococcal disease in catalonia 1 year after mass vaccination campaign with meningococcal group C polysaccharide vaccine.
    Cardeñosa N; Domínguez A; Martínez A; Alvarez J; Pañella H; Godoy P; Minguell S; Camps N; Vázquez JA;
    Infection; 2003 Dec; 31(6):392-7. PubMed ID: 14735381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meningococcal education: more than just a vaccine.
    Kuenzi L
    J Am Coll Health; 2004; 53(2):93-4. PubMed ID: 15495887
    [No Abstract]   [Full Text] [Related]  

  • 29. Meningococcal immunisation in Ghana.
    McDamien D; Boelaert M; Van Damme W; Van der Stuyft P
    Lancet; 2000 Jun; 355(9222):2252; author reply 2252-3. PubMed ID: 10881918
    [No Abstract]   [Full Text] [Related]  

  • 30. Uptake of a new meningitis vaccination programme amongst first-year undergraduate students in the United Kingdom: A cross-sectional study.
    Blagden S; Seddon D; Hungerford D; Stanistreet D
    PLoS One; 2017; 12(8):e0181817. PubMed ID: 28767667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effectiveness of an immunization campaign with group A and C meningococcal polysaccharide vaccine in controlling an outbreak of group C meningococcal disease].
    Gong J; Li CY; Dong BQ; Huang JZ; Quan Y; Lu WZ; Luo CH; Mao WC; Liao HZ; Fang JS; Cui XL; Xie GL; Wu XH; Lan RW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):552-5. PubMed ID: 19040035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Neisseria meningitidis and meningitis].
    Nicolas P; Debonne JM; Martet G
    Med Trop (Mars); 1999; 59(1):68-78. PubMed ID: 10472587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Preventive effectiveness of an urgent mass vaccination with purified meningococcal polysaccharide vaccine observed during a meningitis epidemic].
    Wu C
    Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Dec; 6(6):344-6. PubMed ID: 3938683
    [No Abstract]   [Full Text] [Related]  

  • 34. Meningococcal vaccine in travelers.
    Wilder-Smith A
    Curr Opin Infect Dis; 2007 Oct; 20(5):454-60. PubMed ID: 17762777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meningococcal conjugate vaccine uptake, measured by Michigan's immunization registry.
    Enger KS; Stokley S
    J Adolesc Health; 2007 May; 40(5):398-404. PubMed ID: 17448396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should we plan a general childhood vaccination against bacterial meningitis?
    Mäkelä PH; Peltola H
    Dev Biol Stand; 1979; 43():61-7. PubMed ID: 42596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Meningococcal disease and VA-MENGOC BC in minors less than 1 year of age. Cuba, 1983 to 1991].
    Rico Cordeiro O; Jiménez Barreras R; Pereira Colls C
    Rev Cubana Med Trop; 1996; 48(1):34-9. PubMed ID: 9768267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meningococcal immunisation and protection from epidemics.
    Hassan J; Massougbodji A; Chippaux JP; Massit B; Josse R
    Lancet; 1998 Aug; 352(9125):407-8. PubMed ID: 9717959
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of complement in anti-bacterial defence.
    D'Amelio R; Biselli R
    Ann Ital Med Int; 1994; 9(3):173-7. PubMed ID: 7946895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Editorial retrospective. Meningococcal A and other polysaccharide vaccines. A five-year progress report.
    Lepow ML; Gold R
    N Engl J Med; 1983 May; 308(19):1158-60. PubMed ID: 6403865
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.